| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5945449 | DIALYSIS SUPS | Sterile bicarbonate concentrate |
Oct, 2017
(6 years ago) | |
| US7300674 | DIALYSIS SUPS | Sterile low bicarbonate dialysis concentrate solutions |
Mar, 2023
(1 year, 1 month ago) | |
Normocarb Hf 25 is owned by Dialysis Sups.
Normocarb Hf 25 contains Magnesium Chloride; Sodium Bicarbonate; Sodium Chloride.
Normocarb Hf 25 has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Normocarb Hf 25 are:
- US5945449
- US7300674
Normocarb Hf 25 was authorised for market use on 26 July, 2006.
Normocarb Hf 25 is available in solution;injection dosage forms.
Normocarb Hf 25 can be used as use as replacement solution, hemofiltration solution or hemodiafiltration solution in continuous renal replacement therapy.
The generics of Normocarb Hf 25 are possible to be released after 04 March, 2023.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| Orphan Drug Exclusivity(ODE) | Jul 26, 2013 |
Drugs and Companies using MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE ingredient
Market Authorisation Date: 26 July, 2006
Treatment: Use as replacement solution, hemofiltration solution or hemodiafiltration solution in continuous renal replacement therapy
Dosage: SOLUTION;INJECTION
NORMOCARB HF 25 family patents
